Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds

More articles from Preclinical Probes for Oncology-1

  • You have access
    Differential uptake of CD146-specific antibody in solid lung malignancies
    Christopher England, Haiyan Sun, Rebecca Majewski, Yunan Yang, Todd Barnhart and Weibo Cai
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 336;
  • You have access
    Immuno-PET imaging using 89Zr labeled PD-L1 antibody in non-small cell lung cancer Xenograft
    Dan Li and Xiao-Hua Zhu
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 337;
  • You have access
    89Zr-anti-γH2AX-TAT allows early monitoring of response to gemcitabine and capecitabine therapy in pancreatic ductal adenocarcinoma
    James Knight, Michael Mosley, Luisa Contreras Bravo, Emmanouil Fokas and Bart Cornelissen
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 333;
  • You have access
    Cyclotron production of 58mCo for Auger electron-based targeted radioimmunotherapy and PET imaging post-therapy with the daughter 58gCo
    Hector Valdovinos, Reinier Hernandez, Shreya Goel, Stephen Graves, Todd Barnhart, Weibo Cai and Robert Nickles
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 332;
  • You have access
    In Vivo Characterization of Two PARP Inhibitors Using a Recently Developed PET Imaging Agent in Small Cell Lung Cancer
    Brandon Carney, Susanne Kossatz, Benjamin Lok, John Poirier, Wolfgang Weber, Charles Rudin and Thomas Reiner
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 334;
  • You have access
    68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use
    Simone Dalm, Ingrid Bakker, Erik de Blois, Gabriela Doeswijk, Mark Konijnenberg, Francesca Orlandi, Donato Barbato, Mattia Tedesco, Theodosia Maina, Berthold Nock and Marion de Jong
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 331;
  • You have access
    Micro-PET/CT imaging of Axl expression in breast cancer xenografts and their response to 17-allylamino-17-demethoxygeldanamycin (17-AAG) treatment
    Wanqin Wang, Xiaoxia Wen, Jun Zhao, Chun-Jen Lin, Shiaw-Yih Lin and Chun Li
    Journal of Nuclear Medicine May 1, 2016, 57 (supplement 2) 335;
SNMMI

© 2025 SNMMI

Powered by HighWire